{"entity":{"type":"insider","cik":"0001589991","url":"/insider/0001589991","json_url":"/insider/0001589991.json","name":"Cagle Gerald D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":13,"first":"2014-05-20","last":"2020-05-12","span_basis":"filed_date"},"name_variants":[{"name":"Cagle Gerald D.","source":"filing","n_filings":13,"first_seen":"2014-05-20","last_seen":"2020-05-12"}],"transactions":[{"id":3256747,"accession":"0001209191-20-028588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-028588","line_url":"/filing/0001209191-20-028588#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.27,"price_display":"15.27","price_state":"stated","total_value":76350.0,"total_display":"76,350.00","total_whole":"76,350","shares_owned_after":16550.0,"shares_owned_after_display":"16,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-08","filed_date":"2020-05-12","scope":"insider"},{"id":6804805,"accession":"0001209191-18-059222","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-059222","line_url":"/filing/0001209191-18-059222#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":41.7466,"price_display":"41.75","price_state":"stated","total_value":83493.2,"total_display":"83,493.20","total_whole":"83,493","shares_owned_after":19800.0,"shares_owned_after_display":"19,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-16","filed_date":"2018-11-19","scope":"insider"},{"id":6291586,"accession":"0001209191-18-033483","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-033483","line_url":"/filing/0001209191-18-033483#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":49.45,"price_display":"49.45","price_state":"stated","total_value":49450.0,"total_display":"49,450.00","total_whole":"49,450","shares_owned_after":16050.0,"shares_owned_after_display":"16,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-25","filed_date":"2018-05-25","scope":"insider"},{"id":6454628,"accession":"0001209191-18-032407","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-032407","line_url":"/filing/0001209191-18-032407#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":50.245,"price_display":"50.24","price_state":"stated","total_value":50245.0,"total_display":"50,245.00","total_whole":"50,245","shares_owned_after":15050.0,"shares_owned_after_display":"15,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-21","filed_date":"2018-05-22","scope":"insider"},{"id":6724810,"accession":"0001209191-18-021358","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-021358","line_url":"/filing/0001209191-18-021358#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":11.89,"price_display":"11.89","price_state":"stated","total_value":89175.0,"total_display":"89,175.00","total_whole":"89,175","shares_owned_after":23441.0,"shares_owned_after_display":"23,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-22","filed_date":"2018-03-23","scope":"insider"},{"id":4489035,"accession":"0001209191-17-049039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-049039","line_url":"/filing/0001209191-17-049039#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":7.08,"price_display":"7.08","price_state":"stated","total_value":35400.0,"total_display":"35,400.00","total_whole":"35,400","shares_owned_after":15941.0,"shares_owned_after_display":"15,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-11","filed_date":"2017-08-15","scope":"insider"},{"id":4988873,"accession":"0001209191-17-033038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-033038","line_url":"/filing/0001209191-17-033038#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":39.9,"price_display":"39.90","price_state":"stated","total_value":39900.0,"total_display":"39,900.00","total_whole":"39,900","shares_owned_after":12900.0,"shares_owned_after_display":"12,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-09","filed_date":"2017-05-17","scope":"insider"},{"id":4444816,"accession":"0001209191-17-027736","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-027736","line_url":"/filing/0001209191-17-027736","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":41.7,"price_display":"41.70","price_state":"stated","total_value":83400.0,"total_display":"83,400.00","total_whole":"83,400","shares_owned_after":11900.0,"shares_owned_after_display":"11,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-19","filed_date":"2017-04-20","scope":"insider","n_lines":2},{"id":4322470,"accession":"0001209191-17-029014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-029014","line_url":"/filing/0001209191-17-029014#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14064.0,"shares_display":"14,064","price_per_share":7.1,"price_display":"7.10","price_state":"stated","total_value":99854.4,"total_display":"99,854.40","total_whole":"99,854","shares_owned_after":14064.0,"shares_owned_after_display":"14,064","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-27","filed_date":"2017-05-01","scope":"insider"},{"id":4486426,"accession":"0001209191-17-021777","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-021777","line_url":"/filing/0001209191-17-021777#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.84,"price_display":"6.84","price_state":"stated","total_value":34200.0,"total_display":"34,200.00","total_whole":"34,200","shares_owned_after":10941.0,"shares_owned_after_display":"10,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-16","filed_date":"2017-03-20","scope":"insider"},{"id":2414305,"accession":"0001209191-16-126267","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-126267","line_url":"/filing/0001209191-16-126267#line-2","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2.0,"shares_display":"2","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":14.0,"total_display":"14.00","total_whole":"14","shares_owned_after":5941.0,"shares_owned_after_display":"5,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-07","scope":"insider"},{"id":2923783,"accession":"0001209191-16-115635","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-16-115635","line_url":"/filing/0001209191-16-115635","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":16.5999762,"price_display":"16.60","price_state":"stated","total_value":33199.9524,"total_display":"33,199.95","total_whole":"33,200","shares_owned_after":7724.0,"shares_owned_after_display":"7,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-28","filed_date":"2016-04-26","scope":"insider","n_lines":2},{"id":2923771,"accession":"0001209191-16-115635","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-16-115635","line_url":"/filing/0001209191-16-115635#line-7","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":15.4585,"price_display":"15.46","price_state":"stated","total_value":7729.25,"total_display":"7,729.25","total_whole":"7,729","shares_owned_after":6200.0,"shares_owned_after_display":"6,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-12","filed_date":"2016-04-26","scope":"insider"},{"id":2923767,"accession":"0001209191-16-115635","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-115635","line_url":"/filing/0001209191-16-115635","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1146.0,"shares_display":"1,146","price_per_share":16.375602094240836,"price_display":"16.38","price_state":"stated","total_value":18766.44,"total_display":"18,766.44","total_whole":"18,766","shares_owned_after":5700.0,"shares_owned_after_display":"5,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-10","filed_date":"2016-04-26","scope":"insider","n_lines":4},{"id":2923752,"accession":"0001209191-16-115635","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-115635","line_url":"/filing/0001209191-16-115635#line-2","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":24.54,"price_display":"24.54","price_state":"stated","total_value":12270.0,"total_display":"12,270.00","total_whole":"12,270","shares_owned_after":4554.0,"shares_owned_after_display":"4,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-05","filed_date":"2016-04-26","scope":"insider"},{"id":2923748,"accession":"0001209191-16-115635","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-115635","line_url":"/filing/0001209191-16-115635#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":25.6,"price_display":"25.60","price_state":"stated","total_value":12800.0,"total_display":"12,800.00","total_whole":"12,800","shares_owned_after":4054.0,"shares_owned_after_display":"4,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2016-04-26","scope":"insider"},{"id":6972064,"accession":"0001209191-14-035668","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-035668","line_url":"/filing/0001209191-14-035668#line-1","is_derivative":false,"issuer_cik":"0001337553","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001337553","owner_cik":"0001589991","owner_name":"Cagle Gerald D.","owner_display_name":"Cagle Gerald D.","owner_url":"/insider/0001589991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1854.0,"shares_display":"1,854","price_per_share":15.07,"price_display":"15.07","price_state":"stated","total_value":27939.78,"total_display":"27,939.78","total_whole":"27,940","shares_owned_after":1854.0,"shares_owned_after_display":"1,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-16","filed_date":"2014-05-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":20,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001337553","name":"AERIE PHARMACEUTICALS INC","url":"/issuer/0001337553","role":"Director","n_filings":8,"first_seen":"2014-05-20","last_seen":"2020-05-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001539029","name":"Clearside Biomedical, Inc.","url":"/issuer/0001539029","role":"Director","n_filings":5,"first_seen":"2016-06-07","last_seen":"2018-03-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001589991","retrieved_at":"2026-08-23T04:17:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}